Recombinant Human Bone Marrow Proteoglycan/BMPG (C-6His)

Recombinant Human Bone Marrow Proteoglycan/BMPG (C-6His)

SKU: C818-10ug
Recombinant Human Bone Marrow Proteoglycan is produced by our Mammalian expression system and the target gene encoding Leu17-Tyr222 is expressed with a 6His tag at the C-terminus. Bon Opus Cat. #C818 (BP028)
  • Accession Number

  • Background

    Bone Marrow Proteoglycan (BMPG) is a secreted protein that contains one C-type lectin domain. BMPG is the predominant constituent of the crystalline core of the eosinophil granule. BMPG is highly expressed in placenta and pregnancy serum. BMPG may be involved in antiparasitic defense mechanisms as a cytotoxin and helminthotoxin. BMPG induces non-cytolytic histamine release from human basophils. In addition, BMPG also participated in antiparasitic defense mechanisms and immune hypersensitivity reactions.
  • Expression

    Human Cells
  • Packaging

    Dry Ice/ice packs
  • Formulation

    Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.
  • ALTnames

    Bone Marrow Proteoglycan, BMPG, Proteoglycan 2, Eosinophil Granule Major Basic Protein, EMBP, MBP, Pregnancy-Associated Major Basic Protein, PRG2, MBP
  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA